Skip to main content

Biolase, Inc

BIOLDelisted Sep 6, 2024
Industry
Dental Equipment & Supplies
SEC CIK
0000811240

Biolase, Inc was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 12, 2023; 29 institutions reported holding it in 13F filings for Q2 2023, worth $311.8K in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Biolase, Inc changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of BIOL: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders4142+1
Shares17.5M17.7M+180.4K (+1.0%)
Value$14.8M$12.4M−$2.41M (−16.3%)

New holders (6)

Institutions that held Biolase, Inc at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to BIOL in Q2 2021
InstitutionSharesValue% of portfolio
Virtu Financial LLC220,473$154.0K0.01%
Two Sigma Investments, LP108,877$76.0K0.00%
Two Sigma Advisers, LP52,100$36.0K0.00%
Algert Global LLC18,700$13.0K0.00%
Spire Wealth Management5,000$3.00K0.00%
Bank of America Corp70$00.00%

Sold out (5)

Institutions that held Biolase, Inc at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of BIOL in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Squarepoint Ops LLC17,954$15.0K
Wealthsource Partners, LLC15,000$13.0K
Jane Street Group, LLC13,577$11.0K
Stony Point Wealth Management Inc.11,080$9.00K
International Assets Investment Management, LLC2,018$1.00K